Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 4,450 shares at $199.10 ($883K) on 2025-11-03, disclosed to the SEC on 2025-11-04.
Scheduled sale ($883k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $198.03 | 1,450 | $287K | 32.5% |
| 2 | $198.03 | 1,450 | $287K | 32.5% |
| 3 | $199.10 | 1,450 | $289K | 32.7% |
| 4 | $199.74 | 100 | $20K | 2.3% |
| Total | $198.42 avg | 4,450 | $883K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |